{"name": "Novacea",
 "permalink": "novacea",
 "crunchbase_url": "http://www.crunchbase.com/company/novacea",
 "homepage_url": "",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 9,
 "founded_year": 2001,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "650-228-1800",
 "description": "treatment of cancer",
 "created_at": "Tue Dec 15 21:35:05 UTC 2009",
 "updated_at": "Sun Jun 20 20:31:49 UTC 2010",
 "overview": "\u003Cp\u003EAs of January 30, 2009, Novacea, Inc. was acquired by Transcept Pharmaceuticals, Inc., in a reverse merger transaction. Novacea, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing therapies for the treatment of cancer. The company\u00e2\u20ac\u2122s product candidates include Asentar, which is in Phase III clinical trial for the treatment of androgen-independent prostate cancer and in Phase II clinical trial for the treatment of advanced pancreatic cancer; and AQ4N, a hypoxia-activated prodrug in Phase Ib/IIa clinical trial for the treatment of glioblastoma multiforme. It has license and collaboration agreements with Aventis Pharmaceuticals, Inc.; Oregon Health \u0026amp; Science University; University of Pittsburgh; KuDOS Pharmaceuticals Limited; and BTG International Limited. \u003C/p\u003E\n\n\u003Cp\u003EThe company was founded in 2001 and is headquartered in South San Francisco, California.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "James",
      "last_name": "Blair",
      "permalink": "james-blair",
      "image": null}},
   {"is_past": true,
    "title": "Founding CEO",
    "person":
     {"first_name": "Eckard",
      "last_name": "Weber",
      "permalink": "eckard-weber",
      "image":
       {"available_sizes":
         [[[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-150x150.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-250x250.jpg"],
          [[117,
            142],
           "assets/images/resized/0026/5346/265346v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "400 Oyster Point Boulevard",
    "address2": "Suite 200",
    "zip_code": "94080",
    "city": "San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}